AU2006261641B2 - Protein profile for osteoarthritis - Google Patents

Protein profile for osteoarthritis Download PDF

Info

Publication number
AU2006261641B2
AU2006261641B2 AU2006261641A AU2006261641A AU2006261641B2 AU 2006261641 B2 AU2006261641 B2 AU 2006261641B2 AU 2006261641 A AU2006261641 A AU 2006261641A AU 2006261641 A AU2006261641 A AU 2006261641A AU 2006261641 B2 AU2006261641 B2 AU 2006261641B2
Authority
AU
Australia
Prior art keywords
expression
osteoarthritis
protein
sample
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2006261641A
Other languages
English (en)
Other versions
AU2006261641A1 (en
Inventor
Reuben Gobezie
Bryan Krastins
Peter J. Millett
David A. Sarracino
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Brigham and Womens Hospital Inc
Original Assignee
Brigham and Womens Hospital Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brigham and Womens Hospital Inc filed Critical Brigham and Womens Hospital Inc
Publication of AU2006261641A1 publication Critical patent/AU2006261641A1/en
Application granted granted Critical
Publication of AU2006261641B2 publication Critical patent/AU2006261641B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/105—Osteoarthritis, e.g. cartilage alteration, hypertrophy of bone

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU2006261641A 2005-06-17 2006-06-16 Protein profile for osteoarthritis Ceased AU2006261641B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US69204005P 2005-06-17 2005-06-17
US60/692,040 2005-06-17
PCT/US2006/023619 WO2006138646A2 (en) 2005-06-17 2006-06-16 Protein profile for osteoarthritis

Publications (2)

Publication Number Publication Date
AU2006261641A1 AU2006261641A1 (en) 2006-12-28
AU2006261641B2 true AU2006261641B2 (en) 2011-09-29

Family

ID=37387398

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2006261641A Ceased AU2006261641B2 (en) 2005-06-17 2006-06-16 Protein profile for osteoarthritis

Country Status (6)

Country Link
US (1) US20100292154A1 (https=)
EP (1) EP1894016A2 (https=)
JP (2) JP2008547006A (https=)
AU (1) AU2006261641B2 (https=)
CA (1) CA2615947A1 (https=)
WO (1) WO2006138646A2 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8224579B2 (en) * 2005-06-17 2012-07-17 The Brigham And Women's Hospital, Inc. Method of diagnosing osteoarthritis
AU2008247705B2 (en) * 2007-05-01 2012-02-09 Hill's Pet Nutrition, Inc. Methods and compositions for diagnosing osteoarthritis in a feline
EP2131199A1 (en) * 2008-06-03 2009-12-09 Université de Liège Biomarker for osteoarthritis and/or other ageing-related diseases, and use thereof
US8771968B2 (en) 2008-06-03 2014-07-08 Universitè de Liège Biomarker for osteoarthritis and/or other ageing-related diseases, and use thereof
JP2011117813A (ja) * 2009-12-02 2011-06-16 Hokuriku Univ 変形性関節症のマーカーおよびそれを用いた診断
CA2792163A1 (en) * 2010-03-05 2011-09-09 The Curators Of The University Of Missouri Biomarkers of osteoarthritis
AU2012253691B2 (en) 2011-05-10 2016-05-19 Société des Produits Nestlé S.A. Methods for diagnosing degenerative joint disease
AU2012367247B2 (en) * 2012-01-24 2018-04-05 Cd Diagnostics, Inc. System for detecting infection in synovial fluid
JP6768922B2 (ja) * 2016-04-15 2020-10-14 イーエスエム テクノロジーズ エルエルシーＥＳＭ Ｔｅｃｈｎｏｌｏｇｉｅｓ， ＬＬＣ 関節部治療薬を評価するための方法
JP7421744B2 (ja) * 2019-08-28 2024-01-25 学校法人順天堂 変形性関節症の診断

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994009155A1 (en) * 1992-10-13 1994-04-28 Duke University Methods of detecting alzheimer's disease
WO2002070737A2 (en) * 2001-02-28 2002-09-12 Chondrogene Inc. Compositions and methods relating to osteoarthritis
US20030224989A1 (en) * 2002-02-12 2003-12-04 Kerry Quinn Compositions and methods for treatment of osteoarthritis

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5026651A (en) * 1985-04-25 1991-06-25 Board Of Regents, The University Of Texas System Methods and compositions for the production of human transferrin
US5194596A (en) * 1989-07-27 1993-03-16 California Biotechnology Inc. Production of vascular endothelial cell growth factor
US5350836A (en) * 1989-10-12 1994-09-27 Ohio University Growth hormone antagonists
DE10127572A1 (de) * 2001-05-30 2002-12-05 Pathoarray Gmbh Werkzeuge zur Diagnostik, molekularen Definition und Therapieentwicklung chronischer entzündlicher Gelenkerkrankungen
US20030224386A1 (en) * 2001-12-19 2003-12-04 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of rheumatoid arthritis
JP4538637B2 (ja) * 2003-03-31 2010-09-08 国立大学法人九州大学 アポリポタンパクｅ遺伝子多型検出方法、アポリポタンパクｅ遺伝子多型のゲノタイプ判定方法及び試薬
EP2128270B1 (en) * 2003-08-08 2012-10-03 Genenews Inc. Osteoarthritis biomarkers and uses thereof
WO2006023412A2 (en) * 2004-08-18 2006-03-02 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Biomarkers for osteoarthritis

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994009155A1 (en) * 1992-10-13 1994-04-28 Duke University Methods of detecting alzheimer's disease
WO2002070737A2 (en) * 2001-02-28 2002-09-12 Chondrogene Inc. Compositions and methods relating to osteoarthritis
US20030224989A1 (en) * 2002-02-12 2003-12-04 Kerry Quinn Compositions and methods for treatment of osteoarthritis

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Gerard, H. C. et al. "Frequency of apolipoprotein E (APOE) allele types in patients with Chlamydia-associated arthritis and other arthritides", Microbial Pathogenesis, 1999, Vol. 26, pages 35-43 *
ZHANG, H. et al. "Microarray analysis reveals the involvement of beta-2 microglobulin (B2M) in human osteoarthritis", Osteoarthritis and Cartilage, 2002, Vol. 10, pages 950-960 *

Also Published As

Publication number Publication date
JP2008547006A (ja) 2008-12-25
AU2006261641A1 (en) 2006-12-28
EP1894016A2 (en) 2008-03-05
JP2012073274A (ja) 2012-04-12
US20100292154A1 (en) 2010-11-18
CA2615947A1 (en) 2006-12-28
WO2006138646A3 (en) 2007-06-07
WO2006138646A2 (en) 2006-12-28

Similar Documents

Publication Publication Date Title
WO2010085606A1 (en) Protein biomarkers and therapeutic targets for osteoarthritis
JP2012073274A (ja) 変形性関節症のタンパク質プロフィール
Mobasheri Osteoarthritis year 2012 in review: biomarkers
US20180106817A1 (en) Protein biomarkers and therapeutic targets for renal disorders
US9733257B2 (en) Biomarkers of osteoarthritis
WO2008074029A2 (en) Protein profile for osteoarthritis
US20250172556A1 (en) Biomarkers and methods for assessing response to inflammatory disease therapy withdrawal
WO2008064336A2 (en) Autoimmune disease biomarkers
JP2014074721A (ja) 腎機能監視のための予測的な腎臓安全性生物マーカーおよび生物マーカーサイン
JP2024150669A (ja) 子宮内膜症の診断方法、病態モニタリング方法及びキット
US20090042201A1 (en) Biomarkers for multiple sclerosis and methods of use thereof
WO2007133586A2 (en) Systems and methods for developing diagnostic tests based on biomarker information from legacy clinical sample sets
JP2020500293A (ja) 大腸癌及び進行性腺腫を検知するためのタンパク質バイオマーカーパネル
CA3207751A1 (en) Biomarkers and methods for assessing psoriatic arthritis disease activity
WO2011014349A1 (en) Serum markers predicting clinical response to anti-tnfalpha antibodies in patients with psoriatic arthritis
WO2008131261A2 (en) Peptide biomarkers of cardiovascular disease
US20180292384A1 (en) Urine metabolite profiles identify kidney allograft status
US8372594B2 (en) Secreted phospholipase A2 biomarkers for arthritis
Tachino et al. Plasma proteomics profile-based comparison of torso versus brain injury: A prospective cohort study
AU2015224468B2 (en) Biomarkers of osteoarthritis
Figure International Bureau

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired